Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2281-2290 of 2869 for cancer

Edit search filters
  1. A Study To Evaluate Effectiveness And Quality Of Life Outcomes Of Daratumumab In Relapsed/Refractory Multiple Myeloma Patients

    Rochester, MN

  2. MElanoma Research Lymph Node Prediction Implementation National_001 (MERLIN_001)

    Rochester, MN

  3. A Single Patient Study Of Severe Fibrosis After Breast Radiation

    Rochester, MN

  4. Understanding The Resistance To Enzalutamide In Patients With Castrate Resistant Metastatic Prostate Cancer

    Jacksonville, FL

  5. Identifying Gene Modifiers Of Melanoma And Pancreatic Cancer Susceptibility

    Rochester, MN

  6. Congenital Heart Disease Skin Punch Biopsy Sample Collection

    Rochester, MN

  7. Metabolic Agents Pharmacodynamic Analyses After Brain Radiation

    Rochester, MN

  8. Fertility Outcomes in Lymphoma Patients

    Jacksonville, FL

  9. Tumor Heterogeneity Of The Tumor Microenvironment In Malignant Pleural Mesothelioma (MPM)

    Rochester, MN

  10. Deep Learning-based Automated Segmentation of Organs at Risk in Treat Head and Neck Radiotherapy

    Rochester, MN

.

Mayo Clinic Footer